Coherus Oncology, Inc. Debt Securities, Available-for-sale, Realized Loss
Coherus Oncology, Inc. (CHRS) reported Debt Securities, Available-for-sale, Realized Loss of $0 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss · last filed 2019-11-08
- Coherus Oncology, Inc. debt securities, available-for-sale, realized loss for the quarter ending 2019-09-30 was $0.00.
- Coherus Oncology, Inc. debt securities, available-for-sale, realized loss for the quarter ending 2019-06-30 was $0.00.
- Coherus Oncology, Inc. debt securities, available-for-sale, realized loss for the quarter ending 2019-03-31 was $0.00.
- Coherus Oncology, Inc. debt securities, available-for-sale, realized loss for the quarter ending 2018-09-30 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Loss 3 month | Debt Securities, Available-for-sale, Realized Loss 6 month | Debt Securities, Available-for-sale, Realized Loss 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |